The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
The BSE, founded in 1875, is Asia's oldest stock exchange — it started under a banyan tree on Dalal Street, where the bronze bull stands today.
Hemant Surgical Industries Limited is an India-based company, which manufactures, imports, assembles and markets a comprehensive portfolio of medical equipment and disposables. Its product offerings cover a wide equipment and disposables required for renal care;…
Weekly engine runs — movement reflects the numbers, not analyst opinion.
A decent, fast-growing business.
Hemant Surgical Industries Lim is scored on the pharma / healthcare framework. It keeps a slim 7.7% of every rupee of sales as net profit. Cash conversion lags the reported profit (CFO/PAT 0.49×) — worth a closer look. Free cash flow is worth about -3.3% of its market value.
Over the last 1 years revenue compounded at 113%/yr and profit at 126%/yr. Return on equity is a healthy 13.3%.
It trades at 36× earnings. Today's price implies ~17%/yr earnings growth for a decade. The books come through clean — a forensic grade of A, and Altman puts distress risk in the safe zone.
A plain-English restatement of the figures on this page — rules-based, for education and research context, not investment advice or a recommendation.
| Ratio | Company | Sector | Read |
|---|---|---|---|
| P/E | 35.61 | 36.2 | better |
| P/B | 4.14 | 3.02 | worse |
| ROE | 13.26 | 7.43 | better |
| ROCE | 14.74 | 11.07 | better |
| Peer | P/E | P/B | ROE |
|---|---|---|---|
| Apollo Hospitals | 58.0 | 13.3 | 20.5% |
| Manipal Health Enterpri L | 105.4 | 5.8 | 10.6% |
| Max Healthcare | 66.2 | 9.0 | 13.4% |
Revenue has grown every year across all 2 financial years shown. 113% CAGR over 1 years — high-growth territory.
Net profit has risen every year — the hallmark of a compounder. Profit is growing faster than revenue (126% vs 113%) — margin expansion is at work. The latest year saw a +126% swing — check if it's a one-off or structural.
Operating margins have been stable around 10% — no major structural shift.
P/E band unavailable — needs 5y of consistent EPS + price history.
Promoter holding at 52.8% — majority control intact. Promoters reduced 6.1pp over 4 quarters — watch whether this is planned divestment or pledge invocations.
Produced by a rules-based engine over licensed exchange fundamentals — every sentence above is derived from the numbers shown, no analyst or AI opinion involved. Education and research context, not investment advice. We are not SEBI-registered as an Investment Adviser or Research Analyst.